AbbVie | ABBV - Interest Income


AbbVie reported $59M in Interest Income for its fiscal quarter ending in December of 2025.





Interest Income Change Date
AbbVie USD 59M 13M Dec/2025
Abbott USD 78M 1000K Dec/2025
ALKERMES USD 8.54M 3.59M Mar/2026
AstraZeneca USD 73M 62M Mar/2026
Biogen USD 37.9M 700K Mar/2026
BioMarin Pharmaceutical USD 22.56M 3.35M Mar/2026
Eisai JPY 3.11B 783M Mar/2024
Eli Lilly USD 65M 25M Sep/2025
Gilead Sciences USD 95M 7M Dec/2025
GlaxoSmithKline GBP 22M 96M Mar/2026
J&J USD 2.14 237M Mar/2026
Medtronic USD 114M 23M Jan/2025
Merck USD 69M 27M Dec/2025
Pacira USD 2.3M 6.24M Dec/2025
Pfizer USD 115M 51M Mar/2026
Regeneron Pharmaceuticals USD 193.3M 18.2M Dec/2025
Sanofi EUR 33M 81M Dec/2025
Ultragenyx Pharmaceutical USD 6.51M 649K Dec/2025
United Therapeutics USD 43.2M 3.2M Dec/2025
Vertex Pharmaceuticals USD 114.8M 7.1M Mar/2026
Zoetis USD 25M 1000K Dec/2025